We demonstrated that compared to the untreated control, treatment with 1 mg/mL anti-CDH11 antibody significantly repressed the motility of the metastatic breast cancer cell lines, MCF7 (p < 0.05) and MDA-MB-231 (p < 0.001) (Fig. 3a). The gene discussed is CDH11; the disease is breast cancer.